Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein

Journal of Clinical Investigation

Volumn 97, Issue 12, 1996, Pages 2736-2744

  Murugesan, Gurunathan ^a   Fox, Paul L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

atherosclerosis; cell migration; endothelial cells; lysophospholipids; oxidized low density lipoprotein

Indexed keywords

BEE VENOM; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHATIDYLSERINE; LYSOPHOSPHOLIPID; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHOLIPASE A2; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID;

ANIMAL CELL; AORTA; ARTICLE; CATTLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; ENDOTHELIUM LESION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0029886957     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118728     Document Type: Article

References (71)

1. Schwartz, S.M., C.M. Gajdusek, and S.C. Selden. 1981. Vascular wall growth control: the role of the endothelium. Arteriosclerosis. 1:107-126.
2. Coomber, B.L., and A.I Gotlieb. 1990. In vitro endothelial wound repair. Interaction of cell migration and proliferation. Arteriosclerosis. 10:215-222.
3. Ausprunk, D.H., and J. Folkman. 1977. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc. Res. 14:53-65.
4. Zetter, B.R. 1980. Migration of capillary endothelial cells is stimulated by tumour-derived factors. Nature (Lond.). 285:41-43.
5. Montesano, R., and L. Orci. 1987. Phorbol esters induce angiogenesis in vitro from large-vessel endothelial cells. J. Cell. Physiol. 130:284-291.
6. Connolly, D.T., D.M. Heuvelman, R. Nelson, J.V. Olander, B.L. Eppley, J.J. Delfino, N.R. Siegel, R.M. Leimgruber, and J. Feder. 1989. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84:1470-1478.
7. Rosen, E.M., W. Carley, and I.D. Goldberg. 1990. Scatter factor regulates vascular endothelial cell motility. Cancer Invest. 8:647-650.
8. Koch, A.E., P.J. Polverini, S.L. Kunkel, L.A. Harlow, L.A. DiPietro, V.M. Elner, S.G. Elner, and R.M. Strieter. 1992. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science (Wash. DC). 258:1798-1801.
9. Bjornsson, T.D., M. Dryjski, J. Tluczek, R. Mennie, J. Ronan, T.N. Mellin, and K.A. Thomas. 1991. Acidic fibroblast growth factor promotes vascular repair. Proc. Natl. Acad. Sci. USA. 88:8651-8655.
10. Lindner, V., R.A. Majack, and M.A. Reidy. 1990. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J. Clin. Invest. 85:2004-2008.
11. Keegan, A., C. Hill, S. Kumar, P. Phillips, A. Schor, and J. Weiss. 1982. Purified tumour angiogenesis factor enhances proliferation of capillary, but not aortic, endothelial cells in vitro. J. Cell Sci. 55:261-276.
12. Gotlieb, A.I., W. Spector, K. Desai, and G. Steiner. 1983. The effect of low density lipoprotein on in vitro porcine endothelial cell reendothelialization. Artery. 12:132-144.
13. Tauber, J.P., D. Goldminz, and D. Gospodarowicz. 1981. Up-regulation in vascular endothelial cells of binding sites of high density lipoprotein induced by 25-hydroxycholesterol. Eur. J. Biochem. 119:327-339.
14. Murugesan, G., G. Sa, and P.L. Fox. 1994. High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor. Circ. Res. 74:1149-1156.
15. Madri, J.A., M.A. Reidy, O. Kocher, and L. Bell. 1989. Endothelial cell behavior after denudation injury is modulated by transforming growth factor-β1 and fibronectin. Lab. Invest. 60:755-764.
16. Pepper, M.S., N. Ferrara, L. Orci, and R. Montesano. 1995. Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro. J. Cell Sci. 108:73-83.
17. Murugesan, G., G.M. Chisolm, and P.L. Fox. 1993. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J. Cell Biol. 120:1011-1019.
18. Boissonneault, G.A., Y. Wang, and B.H. Chung. 1995. Oxidized low-density lipoproteins delay endothelial wound healing: Lack of effect of vitamin E. Ann. Nutr. Metab. 39:1-8.
19. Ylä-Herttuala, S. 1991. Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis. Ann. Med. 23:561-567.
20. Henriksen, T., E.M. Mahoney, and D. Steinberg. 1983. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis. 3:149-159.
21. Quinn, M.T., S. Parthasarathy, L.G. Fong, and D. Steinberg. 1987. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. USA. 84:2995-2998.
22. McMurray, H.F., S. Parthasarathy, and D. Steinberg. 1993. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J. Clin. Invest. 92:1004-1008.
23. Autio, I., O. Jaakkola, T. Solakivi, and T. Nikkari. 1990. Oxidized low-density lipoprotein is chemotactic for arterial smooth muscle cells in culture. FEBS Lett. 277:247-249.
24. Hessler, J.R., D.W. Morel, L.J. Lewis, and G.M. Chisolm. 1983. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis. 3:215-222.
25. Parthasarathy, S., D. Steinberg, and J.L. Witztum. 1992. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu. Rev. Med. 43:219-225.
26. Haberland, M.E., and U.P. Steinbrecher. 1992. Modified low-density lipoproteins: Diversity and biological relevance in atherogenesis. Monogr. Hum. Genet. 14:35-61.
27. Addis, P.B., H.A. Emanuel, S.D. Bergmann, and J.H. Zavoral. 1989. Capillary GC quantification of cholesterol oxidation products in plasma lipoproteins of fasted humans. Free Radic. Biol. Med. 7:179-182.
28. Kita, T., Y. Nagano, M. Yokode, K. Ishii, N. Kume, A. Ooshima, H. Yoshida, and C. Kawai. 1987. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA. 84:5928-5931.
29. Gaziano, J.M., J.E. Manson, J.E. Buring, and C.H. Hennekens. 1992. Dietary antioxidants and cardiovascular disease. Ann. N. Y. Acad. Sci. USA. 669:249-258.
30. Chisolm, G.M., G. Ma, K.C. Irwin, L.L. Martin, K.G. Gunderson, L.F. Linberg, D.W. Morel, and P.E. DiCorleto. 1994. 7β-hydroperoxycholest-5-en3β-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc. Natl. Acad. Sci. USA. 91: 11452-11456.
31. Natarajan, V., W.M. Scribner, and M.M. Taher. 1993. 4-Hydroxynonenal, a metabolite of lipid peroxidation, activates phospholipase D in vascular endothelial cells. Free Radic. Biol. Med. 15:365-375.
32. DiCorleto, P.E., and C.A. De la Motte. 1985. Characterization of the adhesion of the human monocytic cell line U937 to cultured endothelial cells. J. Clin. Invest. 75:1153-1161.
33. Fox, P.L., and P.E. DiCorleto. 1986. Modified low density lipoproteins suppress production of a platelet-derived growth factor-like protein by cultured endothelial cells. Proc. Natl. Acad. Sci. USA. 83:4774-4778.
34. Lowry, O.H., N.J. Rosebrough, A.L. Farr, and R.J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
35. Schuh, J., G.F. Fairclough, and R.H. Haschemeyer. 1978. Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc. Natl. Acad. Sci. USA. 75:3173-3177.
36. 2 mimics cell-mediated oxidative modification. J. Lipid Res. 29:745-753.
37. Jougasaki, M., K. Kugiyama, Y. Saito, K. Nakao, H. Imura, and H. Yasue. 1992. Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells. Circ. Res. 71:614-619.
38. Geurts van Kessel, W.S.M., W.MA. Hax, R.A. Demel, and J. de Gier. 1977. High performance liquid chromatographic separation and direct ultraviolet detection of phospholipids. Biochim. Biophys. Acta. 486:524-530.
39. Nakamura, K., and S. Handa. 1984. Coomassie brilliant blue staining of lipids on thin-layer plates. Anal. Biochem. 142:406-410.
40. Kume, N., M.I. Cybulsky, and M.A. Gimbrone, Jr. 1992. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90:1138-1144.
41. Schmidt, K., P. Klatt, W.F. Graier, G.M. Kostner, and W.R. Kukovetz. 1992. High-density lipoprotein antagonizes the inhibitory effects of oxidized low-density lipoprotein and lysolecithin on soluble guanylyl cyclase. Biochem. Biophys. Res. Commun. 182:302-308.
42. Hamilton, T.A., G.P. Ma, and G.M. Chisolm. 1990. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-α mRNA in stimulated murine peritoneal macrophages. J. Immunol. 144:2343-2350.
43. Berliner, J.A., M.C. Territo, A. Sevanian, S. Ramin, J.A. Kim, B. Bamshad, M. Esterson, and A.M. Fogelman. 1990. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85: 1260-1266.
44. Fong, L.G., T.A.T. Fong, and A.D. Cooper. 1991. Inhibition of lipopolysaccharide-induced interleukin-1β mRNA expression in mouse macrophages by oxidized low density lipoprotein. J. Lipid Res. 32:1899-1910.
45. 2 activity of apoprotein B-100. Proc. Natl. Acad. Sci. USA. 87:9741-9745.
46. Quinn, M.T., S. Parthasarathy, and D. Steinberg. 1988. Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherogenesis. Proc. Natl. Acad Sci. USA. 85:2805-2809.
47. Kugiyama, K., S.A. Kerns, J.D. Morrisett, R. Roberts, and P.D. Henry. 1990. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature (Lond.). 344:160-162.
48. Kume, N., and M.A. Gimbrone. 1994. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human vascular endothelial cells. J. Clin. Invest. 93:907-911.
49. Chatterjee, S. 1992. Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation. Mol. Cell. Biochem. 111:143-147.
50. Sakai, M., A. Miyazaki, H. Hakamata, T. Sasaki, S. Yui, M. Yamazaki, M. Shichiri, and S. Horiuchi. 1994. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J. Biol. Chem. 269:31430-31435.
51. Hoffman, R.D., M. Kligerman, T.M. Sundl, N.D. Anderson, and H.S. Shin. 1982. Stereospecific chemoattraction of lymphoblastic cells by gradients of lysophosphatidylcholine. Proc. Natl. Acad. Sci. USA. 79:3285-3289.
52. 2+)-ATPase activity in human erythrocyte membranes by synthetic lysophosphatidic acids and lysophosphatidylcholines. Effects of chain length and degree of unsaturation of the fatty acid groups. Biochim. Biophys. Acta. 812:568-574.
53. Lundbæk, J.A., and O.S. Andersen. 1994. Lysophospholipids modulate channel function by altering the mechanical properties of lipid bilayers. J. Gen. Physiol. 104:645-673.
54. Jalink, K., W.H. Moolenaar, and B. Van Duijn. 1993. Lysophosphatidic acid is a chemoattractant for Dictyostelium discoideum amoebae. Proc. Natl. Acad. Sci. USA. 90:1857-1861.
55. Weltzien, H.U. 1979. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim. Biophys. Acta 559:259-287.
56. Sugiyama, S., K. Kugiyama, M. Ohgushi, K. Fujimoto, and H. Yasue. 1994. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries: role of protein kinase C. Circ. Res. 74: 565-575.
57. Kugiyama, K., M. Ohgushi, S. Sugiyama, T. Murohara, K. Fukunaga, E. Miyamoto, and H. Yasue. 1992. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ. Res. 71:1422-1428.
58. Flavahan, N.A. 1993. Lysophosphatidylcholine modifies G protein-dependent signaling in porcine endothelial cells. Am. J. Physiol. 264:H722-H727.
59. 2 activity. J. Biol. Chem. 269:3219-3225.
60. Switzer, S., and H.A. Eder. 1965. Transport of lysolecithin by albumin in human and rat plasma. J. Lipid Res. 6:506-511.
61. Portman, O.W., and D.R. Illingworth. 1973. Lysolecithin binding to human and squirrel monkey plasma and tissue components. Biochim. Biophys. Acta. 326:34-42.
62. Portman, O.W., and M. Alexander. 1969. Lysophosphatidylcholine concentration and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J. Lipid Res. 10:158-165.
63. Portman, O.W., and D.R. Illingworth. 1974. Metabolism of lysolecithin in vivo and in vitro with particular emphasis on the arterial wall. Biochim. Biophys. Acta. 348:136-144.
64. Subbaiah, P.V., C. -H. Chen, J.D. Bagdade, and J.J. Albers. 1985. Substrate specificity of plasma lysolecithin acyltransferase and the molecular species of lecithin formed by the reaction. J. Biol. Chem. 260:5308-5314.
65. Subbaiah, P.V., and H. Monshizadegan. 1988. Substrate specificity of human lecithin-cholesterol acyltransferase towards molecular species of phosphatidylcholine in native plasma. Biochim. Biophys. Acta 963:445-455.
66. Reidy, M.A., A.W. Clowes, and S.M. Schwartz. 1983. Endothelial regeneration. V. Inhibition of endothelial regrowth in arteries of rat and rabbit. Lab. Invest. 49:569-575.
67. Minick, C.R., M.B. Stemerman, and W. Insull. 1977. Effect of regenerated endothelium on lipid accumulation in the arterial wall. Proc. Natl. Acad. Sci. USA. 74:1724-1728.
68. Walker, L.N., and D.E. Bowyer. 1984. Endothelial healing in the rabbit aorta and the effect of risk factors for atherosclerosis. Hypercholesterolemia. Arteriosclerosis. 4:479-488.
69. Morel, D.W., P.E. DiCorleto, and G.M. Chisolm. 1984. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 4:357-364.
70. Steinbrecher, U.P., S. Parthasarathy, D.S. Leake, J.L. Witztum, and D. Steinberg. 1984. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81:3883-3887.
71. Kalant, N., S. McCormick, and M.A. Parniak. 1991. Effects of copper and histidine on oxidative modification of low density lipoprotein and its subsequent binding to collagen. Arterioscler. Thromb. 11:1322-1329.